Dividends can produce as much as a third of your total return over long periods, and you can even retire on dividends.
There are 4 key stock dividend dates that are involved with dividend payments:
1- The Declaration Date is several weeks in advance of a dividend payment—it’s when company’s board of directors sets the amount and timing of the proposed payment.
2- The Payable Date is the date set by the board on which the dividend will actually be paid out to shareholders.
3- The Record Date is for shareholders who hold the stock before the payable date and receive the dividend payment. That date is set any number of weeks before the payable date.
4-The Ex-Dividend Date is two business days before the record date and it’s when the shares begin to trade without their dividend. If you buy stocks one day or more before their ex-dividend date, you will still get the dividend. That’s when a stock is said to trade cum-dividend. If you buy on the ex-dividend date or later, you won’t get the dividend. The ex-dividend date is in place to allow pending stock trades to settle.
We think very highly of stocks that have been paying dividends for five or more years, at TSI Network. Many of these stocks fit in well with our three-part Successful Investor philosophy:
1- Invest mainly in well-established companies;
2- Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; and Utilities);
3- Downplay or avoid stocks in the broker/media limelight.
[text_ad]
BANK OF MONTREAL $148 is a buy. The bank (Toronto symbol BMO; Income-Growth Dividend Payer Portfolio, Finance sector; Shares outstanding: 648.4 million; Market cap: $96.0 billion; Dividend yield: 3.6%; Dividend Sustainability Rating: Highest; www.bmo.com) last raised your quarterly dividend with the February 2022 payment....
With the March 2022 payment, Archer Daniels raised its quarterly dividend by 8.1%....
These two senior technology companies are shifting into faster-growing fields. Those moves brighten their long-term prospects and should lead to more dividend hikes in the years to come.
INTEL CORP. $48 is a buy. The company (Nasdaq symbol INTC); Conservative Growth Dividend Payer Portfolio, Manufacturing & Industry sector; Shares outstanding: 4.1 billion; Market cap: $196.8 billion; Dividend yield: 3.0%; Dividend Sustainability Rating: Above Average; www.intel.com) is the world’s leading maker of computer chips.
With the March 2022 payment, Intel raised your quarterly dividend by 5.0%....
H&R REAL ESTATE INVESTMENT TRUST $13 is a top pick for 2022. The REIT (Toronto symbol HR.UN; Cyclical-Growth Dividend Payer Portfolio, Manufacturing sector; Units outstanding: 288.4 million; Market cap: $3.7 billion; Distribution yield: 4.0%; Dividend Sustainability Rating: Average; www.hr-reit.com) recently spun off most of its retail properties, including all of its enclosed shopping malls, to a new publicly traded REIT (called Primaris REIT, see box) that it created with the Healthcare of Ontario Pension Plan (HOOPP).
H&R unitholders received one unit of Primaris for every four H&R units they held....
The TD Series 1 preferreds yield 4.0%. That’s higher than the 3.5% offered by the bank’s common shares.
Note, though, that preferred shares behave more like long-term fixed-income instruments than short-term instruments....
As well, a new deal to sell 40% of its Western Canadian gas processing to U.S.-based private equity investor KKR will let Pembina reward its investors with higher dividends and share buybacks later this year.
PEMBINA PIPELINE CORP....
VERIZON COMMUNICATIONS INC....
We continue to see attractive investment opportunities for our subscribers in top drug stocks—and that includes AbbVie Inc. Over the years, meanwhile, we’ve found that spinoffs are about as close as you can get to a sure thing in investing. It’s one key reason why we think AbbVie, itself a spinoff, has further gains ahead for investors. We recommend this stock as a Power Buy.
ABBVIE INC., $156.05, is a buy. The company (New York symbol ABBV; TSINetwork Rating: Above Average) (www.abbvie.com; Shares outstanding: 1.8 billion; Market cap: $275.7 billion; Dividend yield: 3.6%) was formed on January 3, 2013, when Abbott Laboratories (symbol ABT on New York) split into two publicly traded companies.
Since its spinoff from Abbott Laboratories, AbbVie has depended heavily on its Humira drug to drive both its sales and earnings....